Hims & Hers Health, Inc. (HIMS): Capital Expenditures

Annual figures by period end, from SEC filings.

$242.60M
Year ended 2025-12-31
$201.80M
Trailing 12 months to 2026-06-30
+223.0%
3-year compound annual growth
2022-12-31: $7.20M2023-12-31: $26.50M2024-12-31: $52.80M2025-12-31: $242.60M$242.60M
2022-12-31 Capital Expenditures (USD) 2025-12-31
Period endedCapital ExpendituresChange YoYSource filing
2025-12-31$242.60M+359.5%2026-02-23, From 2025-01-01
2024-12-31$52.80M+99.2%2026-02-23, From 2024-01-01
2023-12-31$26.50M+268.1%2026-02-23, From 2023-01-01
2022-12-31$7.20Mn/a2025-02-24, From 2022-01-01

Capital Expenditures at similar companies

Companies with the same SEC industry code (Services-Offices & Clinics of Doctors of Medicine), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedCapital ExpendituresChange YoY
Hims & Hers Health, Inc. (HIMS)2025-12-31$242.60M+359.5%
Teladoc Health, Inc. (TDOC)2025-12-31$8.89M-17.6%
Starling Oncology, Inc. (STLN)2025-12-31$3.20M-15.5%
LifeMD, Inc. (LFMD)2025-12-31$1.87M+27.8%
SBC Medical Group Holdings Inc (SBC)2025-12-31$1.40M-45.4%
Airsculpt Technologies, Inc. (AIRS)2025-12-31$2.40M-82.8%
HealthLynked Corp (HLYK)2024-12-31$2.6K+73.2%

Compare HIMS, TDOC, STLN, LFMD side by side · Screen every company in Services-Offices & Clinics of Doctors of Medicine ↗